SELLAS Life Sciences Group (RXK3.F) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.16
-0.12
-0.09
-0.06

Details

Expected EPS
-0.09383115
Actual EPS
-0.06255410000000002
Surprise EPS
0.03
Surprise Percent
+33.33%

Description

SELLAS Life Sciences Group (RXK3.F) has reported earnings of -0.06255410000000002 per share for Q2 2025.

0 Comments

Share your thoughts